A few weeks ago, we attended the ASCO Annual Meeting which brought the latest oncology developments.
The meeting provides an exceptional opportunity to connect with one of the largest, most diverse audiences in global cancer care and we were extremely proud to be a part of it.
ASCO always delivers truly ground-breaking and practice changing data.
Our Oncology Research Directors, Siobhan Davies, Lindsay Widger and Paula Coyle, have identified their top three themes from ASCO 2023.
- KEYNOTE-671 muddying the waters further in early-stage resectable NSCLC
- Progress for CAR-T is celebrated but balanced by a spotlight on disparities and challenges
- Ongoing explosion of precision medicine and the need to overcome logistical complexities to succeed
Take a look at our article to gain a deeper understanding on these topics.
We hope you found our findings from ASCO interesting.
Please contact our Oncology Directors to discuss your oncology research needs.